Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.09.21.677656

Altered MicroRNA Signatures in Circulating Extracellular Vesicles Reflect Aortic Dilation in Takayasu Arteritis

Abstract

BackgroundTakayasu arteritis (TAK) is a large-vessel vasculitis characterized by progressive inflammation that can lead to stenosis or aneurysmal dilation. Reliable circulating biomarkers for vascular remodeling are lacking, and extracellular vesicles (EVs), which transport molecular cargo that reflects their cellular origin, have emerged as potential biomarkers and modulators of vascular inflammation. However, their role in TAK remains unclear. This study aimed to investigate the relationship between EV-derived microRNA (miRNA) signatures and clinically relevant vascular phenotypes, with a primary focus on aortic dilation. MethodsCirculating small EVs (sEVs) were isolated from the serum of patients with TAK and healthy controls, characterized by high-sensitivity flow cytometry, were profiled for miRNA content, and analyzed using bioinformatic pathway enrichment. In vitro assays were employed in assessing their impact on endothelial activation, while the diagnostic performance of miRNAs was compared to conventional biomarkers and clinical parameters. ResultssEVs from patients with TAK upregulated the endothelial expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, thereby enhancing monocyte adhesion in vitro, consistent with a pro-inflammatory phenotype. Differentially expressed miRNAs were enriched in PI3K-Akt signaling, with phosphatase and tensin homolog identified as a key predicted target. Among patients, miR-223-3p was selectively downregulated in those with aortic dilation, regardless of disease activity or treatment status. Receiver operating characteristic analysis showed that miR-223-3p identified aortic dilation with an area under the curve of 0.748, outperforming C-reactive protein and erythrocyte sedimentation rate. Flow cytometric analysis suggested that platelet-derived EVs represent a predominant source of circulating miR-223-3p, and their proportion tended to be reduced in patients with aortic dilation. ConclusionsReduced platelet-derived EV-associated miR-223-3ps are associated with aortic dilation in TAK and demonstrate superior diagnostic accuracy over conventional inflammatory markers. EV miRNA profiling may provide a novel approach for evaluating vascular remodeling in TAK.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kawajiri, K., Nakagama, S., Sasano, T., Maejima, Y.. 2025-09-23. Altered MicroRNA Signatures in Circulating Extracellular Vesicles Reflect Aortic Dilation in Takayasu Arteritis. https://doi.org/10.1101/2025.09.21.677656

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ksp37 is a rapidly mobilized NK cell secretory protein that engages FGF2

A key feature of natural killer (NK) cells is their preloaded arsenal of effector molecules, allowing them to rapidly respond upon activation. In this study, we characterized a previously unexplored secretory protein, termed killer-specific secretory protein of 37 kDa (Ksp37), which is highly abundant in differentiated CD56dim NK cells. Ksp37 is rapidly secreted in a dose-dependent and JAK-1 dependent manner upon low levels of cytokine stimulation, making it a sensitive readout for NK cell activation. Following secretion, intracellular levels were rapidly replenished, preserving responsiveness to subsequent cytokine stimulation. We found that Ksp37 is stored in polarized intracellular compartments distinct from those containing canonical cytotoxic effector molecules, including granzyme B and perforin, which require stronger stimulation for release. Lastly, we identified Ksp37 as a novel binding partner of fibroblast growth factor 2 (FGF2). This opens new avenues of exploration for the role of NK cells in remodeling their extracellular environment by modulating the FGF2-FGFR1 axis, which plays a key role in tumor growth, angiogenesis and tissue repair.

immunology↗

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗